title: Squamous metaplasia of the conjunctiva: a previously unrecognized adverse effect of risedronate sodium.
authors: Department of Ophthalmology, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA
authors: Ivayla I
authors: II
authors: Geneva
authors: Ralph C
authors: RC
authors: Eagle
authors: Ann
authors: A
authors: Barker-Griffith
authors: Mary
authors: M
authors: Stefanyszyn
authors: Robert
authors: R
authors: Weisenthal
mesh_terms: D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D003228:Conjunctiva / Q000473:pathology*; D003229:Conjunctival Diseases / Q000139:chemically induced* / Q000175:diagnosis; D004847:Epithelial Cells / Q000473:pathology*; D012968:Etidronic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008679:Metaplasia / Q000139:chemically induced; D008875:Middle Aged; D000068296:Risedronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D000068296:Risedronic Acid; D012968:Etidronic Acid